These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 21714776

  • 1. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO, Young PM, Rogueda P, Lallement A, Iliev I, Traini D.
    Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
    [Abstract] [Full Text] [Related]

  • 2. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA, Donohue JF.
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Common lung conditions: chronic obstructive pulmonary disease.
    Delzell JE.
    FP Essent; 2013 Jun; 409():23-31. PubMed ID: 23767419
    [Abstract] [Full Text] [Related]

  • 7. [Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD].
    Yıldırım N.
    Tuberk Toraks; 2010 Jun; 58(2):192-201. PubMed ID: 20865575
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.
    Pelaia G, Muzzio CC, Vatrella A, Maselli R, Magnoni MS, Rizzi A.
    Expert Opin Pharmacother; 2015 Jun; 16(13):2009-21. PubMed ID: 26194120
    [Abstract] [Full Text] [Related]

  • 12. Future of chronic obstructive pulmonary disease management.
    D'Urzo A, Vogelmeier C.
    Expert Rev Respir Med; 2012 Jun; 6(3):285-99. PubMed ID: 22788943
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
    Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, Au DH.
    COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA.
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [Abstract] [Full Text] [Related]

  • 17. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M, Nakamura H, Takahashi S, Chubachi S, Sasaki M, Haraguchi M, Terai H, Ishii M, Fukunaga K, Tasaka S, Soejima K, Asano K, Betsuyaku T, Keio COPD Comorbidity Research (K-CCR) group.
    Int J Chron Obstruct Pulmon Dis; 2015 Oct; 10():1053-9. PubMed ID: 26082629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.